• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TF-19A
Medical Device Problem Codes Calcified (1077); Device Stenosis (4066)
Health Effect - Clinical Codes Aortic Valve Stenosis (1717); Heart Failure/Congestive Heart Failure (4446)
Date of Event 06/30/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2016, a 19mm trifecta valve was implanted during an aortic valve replacement.On (b)(6) 2023, the patient received outpatient treatment for heart failure, and the patient had aortic stenosis symptoms.On (b)(6) 2023, the valve was explanted and replaced with a 23mm epic supra valve.On the explanted valve, calcification was observed around the inflow side, and the left coronary cusp was immobile.The patient was reported to be discharged.The native valve was reported to be 25mm in annulus diameter.There was no history of chronic renal insufficiency, hyperparathyroidism, hypercholesterolemia, diabetes mellitus.
 
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
Explant of the valve due to stenosis was reported.The investigation found that all three leaflets contained calcifications and had fibrous thickening.There was circumferential fibrous pannus ingrowth on the inflow surface which narrowed the inflow diameter of the valve.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The calcifications and pannus noted on the valve could have contributed to the stenosis reported.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Event or Problem Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17399257
Report Number2135147-2023-03208
Device Sequence Number14954449
Product Code LWR
UDI-Device Identifier05414734052016
UDI-Public05414734052016
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P100029
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/28/2018
Device Catalogue NumberTF-19A
Device Lot NumberBR00006958
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/14/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/03/2023
Supplement Date Received by Manufacturer08/15/2023
Initial Report FDA Received Date07/26/2023
Supplement Report FDA Received Date08/21/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/29/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age85 YR
Patient SexFemale
Patient Weight54 KG
-
-